SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-16-014550
Filing Date
2016-11-07
Accepted
2016-11-07 06:13:06
Documents
44
Period of Report
2016-09-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm 10-Q 677682
2 ex31-1.htm EX-31.1 7547
3 ex31-2.htm EX-31.2 7838
4 ex32-1.htm EX-32.1 5941
  Complete submission text file 0001493152-16-014550.txt   3167109

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE FILE rttr-20160930.xml EX-101.INS 463063
6 XBRL SCHEMA FILE rttr-20160930.xsd EX-101.SCH 36900
7 XBRL CALCULATION FILE rttr-20160930_cal.xml EX-101.CAL 32933
8 XBRL DEFINITION FILE rttr-20160930_def.xml EX-101.DEF 145629
9 XBRL LABEL FILE rttr-20160930_lab.xml EX-101.LAB 281653
10 XBRL PRESENTATION FILE rttr-20160930_pre.xml EX-101.PRE 203577
Mailing Address 1880 CENTURY PARK EAST, SUITE 1000 LOS ANGELES CA 90067
Business Address 1880 CENTURY PARK EAST, SUITE 1000 LOS ANGELES CA 90067 310-203-1000
RITTER PHARMACEUTICALS INC (Filer) CIK: 0001460702 (see all company filings)

IRS No.: 263474527 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37428 | Film No.: 161976480
SIC: 2834 Pharmaceutical Preparations